VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2021

Feb 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2021-02-05

Reporting Person: Parini Michael (EVP, Chief Adm, Leg & BD Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-05	Common Stock	M	1930	$86.52	Acquired	59157	Direct
2021-02-05	Common Stock	S	1930	$215.00	Disposed	57227	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-05	Common Stock	$86.52	M	1930	Disposed	2027-02-02	Common Stock (1930)	Direct

Footnotes

F1: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F2: Fully vested.